ClinicalTrials.gg
RecruitingNCT05776706Updated Nov 19, 2026

Clinical Trial for the Validation of AR Based Neuronavigation System

An interventional study of AR-based navigation in Brain Neoplasms, Cerebral Aneurysm and Cerebral Arteriovenous Malformation, sponsored by Seoul National University Hospital. Recruiting at 2 sites in South Korea. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-19.

Sponsored by Seoul National University Hospital · Not applicable, Interventional, and Other

How we know

From the registry’s dates

  • Started Sep 2026; still recruiting 2 months later.
Updated Nov 19, 2026Now RecruitingStart date moved+5 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
80
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 52 studies in Brain Neoplasms with a site in Korea, Republic of — 10 open to participants now, 12 under way, 3 of them phase 3. Brain Neoplasms · Korea, Republic of.

Planned enrollment
27th of 46
80 · median 100
Started
2026
with 2 others
No phase
14 of 52
2 open now
Primary completion
2026-12
later than 4 of 11 live
Registered
45th of 52
by date
Lead sponsor
8 of 52
Seoul National University Hospital

Among the 52 studies in Brain Neoplasms with a site in Korea, Republic of, this one is the 27th largest by planned enrollment of the 46 interventional ones that give a count, is one of 3 that started in 2026, is one of 14 with no phase, reaches primary completion later than 4 of the 11 other live ones, and was the 45th registered.

Brain Neoplasms

2,447 studies on the registry are indexed under Brain Neoplasms; 546 are open to participants now.

Browse Brain Neoplasms studies →

Open to participants now

10 of the 52 studies in Brain Neoplasms with a site in Korea, Republic of are open now. Recruiting first, the newest first:

4 more — sign in →

All 10 open studies →

A study can be open while its sites in Korea, Republic of have not opened yet or have stopped. Only those recruiting at a site in Korea, Republic of →

Who these studies take

Of the 429 Brain Neoplasms studies recruiting now, 289 (67%) set no upper age limit and 83 (19%) stop at 75 or younger; 80 take children under 18; 37 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 52 studies in Brain Neoplasms with a site in Korea, Republic of, or all of them as a file.
02

Study summary

The goal of this clinical trial is to test augmented reality (AR) based neuronavigation system in surgeries for patients of brain neoplasm or cerebral vascular disease. The main questions it aims to answer are:

  • AR based neuronavigation system can achieve accuracy that is not inferior to conventional intraoperative navigation system.

Participants will participate the study after informed consent. When participants undergo surgery for their brain tumor, we will set up 2 types of neuronavigation, conventional navigation system and developed AR based neuronavigation system. Surgeon will plan and conduct surgery based on only conventional navigation system, but 3D errors at several selected points between two types of navigation will be measured and analyzed.

Read the detailed description

Being developed AR navigation were reported in our following papers:

  1. Dho YS, et al., Development of an inside-out augmented reality technique for neurosurgical navigation. Neurosurgical Focus. 2021 Aug 1;51(2):E21. (doi.org/10.3171/2021.5.FOCUS21184)
  2. Moon HC, et al., Navigation of frameless fixation for gamma knife radiosurgery using fixed augmented reality. Scientific Reports. 2022 Mar 16;12(1):1-0. (doi.org/10.3171/2021.5.FOCUS21184)

This study aims to evaluate the accuracy of anatomical localization of a newly developed augmented reality-based neurosurgery navigation. After 3-dimensional (3D) modeling of the brain of a patient with brain tumor or cerebral vascular disease through 3D image segmentation extraction and modeling, the Augmented Reality (AR)-based navigation developed by this research team can be used with a commercially available visualization device, such as iPad, iPhone, and Hololens2, to evaluate the accuracy.

The AR-based navigation obtained approval from the Ministry of Food and Drug Safety of Republic of Korea (class 2 medical device) in February 2022. Through this clinical tria that compare accuracy with existing conventional intraoperative neuronavigation system, we will evaluate whether it shows equivalent performance to replace the existing navigation.

03

Conditions studied

  • Brain Neoplasms
  • Cerebral Aneurysm
  • Cerebral Arteriovenous Malformation
  • Navigation, Spatial

Keywords

  • augmented reality
  • neuronavigation
  • brain neoplasms
  • cerebral arteriovenous malformation
  • cerebral aneurysm
04

Who can participate

The criteria were revised on the registry on Nov 19, 2026. See what changed

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults aged 18 years or older with a brain tumor or cerebrovascular disease who have undergone preoperative CT
  • Scheduled for surgical treatment of the brain tumor or cerebrovascular disease
  • Surgical position allowing exposure and measurement of bilateral Kocher's points and the glabella without significant head rotation

Exclusion criteria

Exclusion Criteria:

  • Patient or legal representative does not consent to participation, including consent to intraoperative video recording
  • Anatomical deformity of the skull or facial region due to previous surgery or other causes that precludes identification of Kocher's points or the glabella
  • Emergency surgery
  • Surgical position (e.g., prone, lateral rotation of 90° or more) that does not allow simultaneous exposure of bilateral Kocher's points and the glabella
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
80 participants (estimated)

Study arms

  • Experimental
    Single arm

    We will set up 2 navigation systems, newly developed AR-based navigation and conventional navigation system, to surgeries of all participants. Surgeons will perform all surgical planning and operations with reference to the conventional navigation system. In this process, the errors of the existing navigation and the newly developed navigation will be measured and compared in 3D at several points, and the points are as follows: 1. Fiducial markers 2. Nasion 3. Tumor's margin (anterior, posterior, superior, inferior)

    Device: AR-based navigation

Interventions

  • DeviceAR-based navigation

    Patient-specific 3D models are generated from preoperative CT using MEDIP PRO and displayed on a tablet (iPad) via MEDIP PRO AR, superimposed on the patient using markerless surface registration. Registration and TRE measurement are video-recorded for retrospective analysis of registration time. The device is used for accuracy evaluation only and does not guide any surgical step.

06

What researchers measure

Primary outcomes

  1. Target Registration Error (TRE) of AR-based navigation at anatomical landmarks

    Linear distance (mm) between the landmark position displayed by MEDIP PRO AR and the actual position on the patient's skin/skull surface, measured directly with a ruler at three fixed landmarks per participant (right Kocher's point, left Kocher's point, glabella). Measured immediately after registration (pre-drape). Reported as mean ± SD or median (IQR) overall and per landmark.

    Time frame: Intraoperative, immediately after AR registration before surgical draping on the day of surgery

  2. Registration time of AR-based navigation

    Time (minutes, seconds) from AR software launch to completion of registration, determined by retrospective analysis of intraoperative video recording. Reported separately for manual and automatic registration.

    Time frame: Intraoperative, on the day of surgery

Secondary outcomes

  1. Post-drape TRE after QR marker-based registration restoration

    TRE (mm) at the same three landmarks measured after surgical draping and restoration of registration using QR markers attached to the skin.

    Time frame: Intraoperative, immediately after draping, on the day of surgery

  2. Incidence of registration drift after draping

    Proportion of landmarks showing visible displacement of the AR overlay of ≥7.5 mm after draping, assessed on a second tablet held in a fixed mount.

    Time frame: Intraoperative, immediately after draping, on the day of surgery

  3. Adverse events and device malfunctions

    Number and description of adverse events and device errors occurring during AR navigation application.

    Time frame: Intraoperative through end of surgery, on the day of surgery

  4. One-step processing time from CT acquisition to 3D model delivery (SNUH only)

    Total elapsed time from CT image receipt on the server to delivery of the 3D mesh to the tablet, including automatic segmentation, calculated from system log timestamps. Success of automatic segmentation (no manual correction required) is also recorded.

    Time frame: Preoperative, within 24 hours before surgery

07

Study locations

1 of 2 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Sep 2026 (actual). Primary completion is estimated for Dec 2026, 3 months after the start.

Of 310 non-industry interventional studies with no phase under Brain Neoplasms, half reached primary completion within 65 months of starting (the median), counting those still running; a quarter within 36 and three quarters within 126. This study's planned 3 months is below that.

Counting every sponsor, half of 321 studies reached it within 64 months; a quarter within 35 and three quarters within 125.

Start moved once since we started tracking on Sep 25, 2026: May 2025 → Sep 2026, on Nov 19, 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Dec 5, 2022
First posted
Mar 20, 2023
StartActual
Sep 8, 2026was May 2025
Primary completionEst.
Dec 31, 2026
CompletionEst.
Dec 31, 2027
Last update
Nov 19, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Recruiting
changed Nov 19, 2026
Sites
1 site added
Show site
  • Seoul National University Hospital · Seoul, South Korea
Nov 19, 2026
Start date
May 1, 2025→Sep 8, 2026 (actual)
Nov 19, 2026
Eligibility
Maximum age 85 Years→none; 1 inclusion criterion edited, 2 added, 1 removed; 4 exclusion criteria added, 3 removed
What changed in the criteria
Inclusion criteria
  • RemovedAdult patients aged 18 years or older who underwent MRI or CT scan due to brain tumor or cerebrovascular disease
  • EditedAdult patientsAdults aged 18 years or older who need surgical treatment using navigation forwith a brain tumor or cerebrovascular disease who have undergone preoperative CT
  • AddedScheduled for surgical treatment of the brain tumor or cerebrovascular disease
  • AddedSurgical position allowing exposure and measurement of bilateral Kocher's points and the glabella without significant head rotation
Exclusion criteria
  • RemovedCases where application of navigation is not necessary according to the judgment of the researcher or surgeon
  • RemovedWhen the patient or guardian does not agree
  • RemovedPatients with anatomical deformation due to previous surgery or requiring emergency surgery
  • AddedPatient or legal representative does not consent to participation, including consent to intraoperative video recording
  • AddedAnatomical deformity of the skull or facial region due to previous surgery or other causes that precludes identification of Kocher's points or the glabella
  • AddedEmergency surgery
  • AddedSurgical position (e.g., prone, lateral rotation of 90° or more) that does not allow simultaneous exposure of bilateral Kocher's points and the glabella
Nov 19, 2026
Interventions
Added Device: AR-based navigation; removed Diagnostic test: AR-based navigation
Nov 19, 2026
Primary outcomes
2 added, 2 removed
What changed in the outcomes
  • AddedTarget Registration Error (TRE) of AR-based navigation at anatomical landmarksTime frame: Intraoperative, immediately after AR registration before surgical draping on the day of surgery
  • AddedRegistration time of AR-based navigationTime frame: Intraoperative, on the day of surgery
  • RemovedThe degree of 3-dimensional error at each measurement points (mm)Time frame: 6 hours
  • RemovedThe degree of 3-dimensional error at each measurement points (mm) after durotomyTime frame: 6 hours
Nov 19, 2026
Secondary outcomes
4 added, 3 removed
What changed in the outcomes
  • AddedPost-drape TRE after QR marker-based registration restorationTime frame: Intraoperative, immediately after draping, on the day of surgery
  • AddedIncidence of registration drift after drapingTime frame: Intraoperative, immediately after draping, on the day of surgery
  • AddedAdverse events and device malfunctionsTime frame: Intraoperative through end of surgery, on the day of surgery
  • AddedOne-step processing time from CT acquisition to 3D model delivery (SNUH only)Time frame: Preoperative, within 24 hours before surgery
  • RemovedNon-inferiority of AR-based navigation compared to conventional navigationTime frame: 12 months
  • RemovedTime required to set up and use each navigationTime frame: 6 hours
  • RemovedEconomic analysis for each navigationTime frame: 12 months
Nov 19, 2026
Contact
Study contact changed: k•••@gmail.com · •••1217→m•••@gmail.com · •••2357. See the current contact
Nov 19, 2026
Show all 1 update
  1. Nov 19, 2026
    Not yet recruiting→Recruiting
    1 site added
    Show site
    • Seoul National University Hospital · Seoul, South Korea
    Start date May 1, 2025→Sep 8, 2026 (now actual)
    Eligibility Maximum age 85 Years→none; 1 inclusion criterion edited, 2 added, 1 removed; 4 exclusion criteria added, 3 removed
    What changed in the criteria
    Inclusion criteria
    • RemovedAdult patients aged 18 years or older who underwent MRI or CT scan due to brain tumor or cerebrovascular disease
    • EditedAdult patientsAdults aged 18 years or older who need surgical treatment using navigation forwith a brain tumor or cerebrovascular disease who have undergone preoperative CT
    • AddedScheduled for surgical treatment of the brain tumor or cerebrovascular disease
    • AddedSurgical position allowing exposure and measurement of bilateral Kocher's points and the glabella without significant head rotation
    Exclusion criteria
    • RemovedCases where application of navigation is not necessary according to the judgment of the researcher or surgeon
    • RemovedWhen the patient or guardian does not agree
    • RemovedPatients with anatomical deformation due to previous surgery or requiring emergency surgery
    • AddedPatient or legal representative does not consent to participation, including consent to intraoperative video recording
    • AddedAnatomical deformity of the skull or facial region due to previous surgery or other causes that precludes identification of Kocher's points or the glabella
    • AddedEmergency surgery
    • AddedSurgical position (e.g., prone, lateral rotation of 90° or more) that does not allow simultaneous exposure of bilateral Kocher's points and the glabella
    Primary outcomes 2 added, 2 removed
    What changed in the outcomes
    • AddedTarget Registration Error (TRE) of AR-based navigation at anatomical landmarksTime frame: Intraoperative, immediately after AR registration before surgical draping on the day of surgery
    • AddedRegistration time of AR-based navigationTime frame: Intraoperative, on the day of surgery
    • RemovedThe degree of 3-dimensional error at each measurement points (mm)Time frame: 6 hours
    • RemovedThe degree of 3-dimensional error at each measurement points (mm) after durotomyTime frame: 6 hours
    Secondary outcomes 4 added, 3 removed
    What changed in the outcomes
    • AddedPost-drape TRE after QR marker-based registration restorationTime frame: Intraoperative, immediately after draping, on the day of surgery
    • AddedIncidence of registration drift after drapingTime frame: Intraoperative, immediately after draping, on the day of surgery
    • AddedAdverse events and device malfunctionsTime frame: Intraoperative through end of surgery, on the day of surgery
    • AddedOne-step processing time from CT acquisition to 3D model delivery (SNUH only)Time frame: Preoperative, within 24 hours before surgery
    • RemovedNon-inferiority of AR-based navigation compared to conventional navigationTime frame: 12 months
    • RemovedTime required to set up and use each navigationTime frame: 6 hours
    • RemovedEconomic analysis for each navigationTime frame: 12 months
    Interventions Added Device: AR-based navigation; removed Diagnostic test: AR-based navigation
    Contact Study contact changed: k•••@gmail.com · •••1217→m•••@gmail.com · •••2357. See the current contact
    + 2 other changes: identifiers and verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT05776706
Responsible party
Chul-Kee Park (Professor, Seoul National University Hospital) — Principal investigator
First posted
Mar 20, 2023
Start date
Sep 8, 2026
Primary completion
Dec 31, 2026 (estimated)
Completion
Dec 31, 2027 (estimated)
Last update
Nov 19, 2026

Study contacts

Sun Mo Nam, MD
Contact
md.nsm.ns@gmail.com
+82020722357
Chul-Kee Park, MD, PhD
Contact
nsckpark@snu.ac.kr
+82220720347

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion